Clinical Trials
23 trialsIMPACT-AML
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Pegasus 2
University Hospital, Brest
Spotlight
Blue Earth Diagnostics
REVELATE
Blue Earth Diagnostics
Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.
Blue Earth Diagnostics
Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients
Fondazione EMN Italy Onlus
STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STANDARD SCHEDULE VERSUS A NEW ALGORITHM OF DOSE REDUCTIONS IN ELDERLY AND UNFIT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE PLUS STEROIDS
Fondazione EMN Italy Onlus
CONDOR
Progenics Pharmaceuticals, Inc.
RITE-USA
Medical Enterprises Ltd.
Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut
Philipps University Marburg
Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma
GE Healthcare
proSPECT-AS
Molecular Insight Pharmaceuticals, Inc.
SOS2
Ospedale Santa Croce-Carle Cuneo
Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients
Gruppo Italiano per lo Studio del Mieloma Multiplo
GAINED
The Lymphoma Academic Research Organisation
NORSPAN Transdermal Patches Phase III Study In Non-Cancer Pain
Mundipharma (China) Pharmaceutical Co. Ltd
ELPET
Ontario Clinical Oncology Group (OCOG)
Positronic Emission Tomography (PET) Imaging in Post Radiation Evaluation of Head and Neck Tumours (PET PREVENT Trial)
Ontario Clinical Oncology Group (OCOG)
Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial)
Ontario Clinical Oncology Group (OCOG)
BIOPRES
Amphia Hospital
Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients
Azienda Ospedaliera San Giovanni Battista
PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)
Ontario Clinical Oncology Group (OCOG)
The DANTE Trial. A Randomized Study on Lung Cancer Screening With Low-Dose Spiral Computed Tomography
Istituto Clinico Humanitas